New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

Higher SUA levels were associated with a lower risk for osteoporosis, with sex, race, diabetes status, and serum cholesterol levels identified as potential modifiers.

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including osteoporosis and gout.

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

An AI tool could flag patients at risk for osteoporosis or osteopenia by evaluating standard hip and pelvis x-rays, new ...

Research links regular exercise to better bone density. Scientists found that people who were more sedentary were less likely to have good bone density. Doctors generally recommend a specific exercise ...

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...